GUFIC BIOSCIENCES
Back to Balance Sheet
|
GUFIC BIOSCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | |
|---|---|---|---|
| Total Non-Current Liabilities | ₹160 Cr | ₹181 Cr | ₹188 Cr |
What is the latest Total Non-Current Liabilities ratio of GUFIC BIOSCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹160 Cr |
| Mar2025 | ₹181 Cr |
| Mar2024 | ₹188 Cr |
How is Total Non-Current Liabilities of GUFIC BIOSCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹160 Cr | -11.73 | |
| Mar2025 | ₹181 Cr | -3.83 | |
| Mar2024 | ₹188 Cr | - | |
Compare Total Non-Current Liabilities of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹4,217.1 Cr | 3% | 7.6% | 9.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 1.6% | -1% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 1.7% | 10.1% | 49.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.5% | -1.2% | 38.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | 0.7% | -3.5% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -1.3% | 0.1% | -7.8% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | 3% |
7.6% |
9.7% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
You may also like the below Video Courses